期刊文献+

经皮选择性肝脏隔离灌注化疗方法学研究 被引量:4

Methodological study on percutaneous selective ioslated hepatic perfusion chemotherapy
下载PDF
导出
摘要 目的 探讨经皮选择性隔离肝脏灌注化疗的可行性及隔离效果。方法 将 12只猪随机分为两组 :HAI组 6只 ,进行常规经肝动脉灌注化疗 ;PSIHP组 6只 ,利用介入放射学方法进行经皮选择性隔离肝脏灌注化疗结合血液灌流。化疗药物选用 5 -FU ,分别检测肝静脉及外周血液中的血药浓度。结果 HAI组肝静脉血 (过滤前 )和外周静脉血浓度峰值分别为 (4 15 3 4± 4 30 2 ) ,(16 76 1± 2 2 6 9)mg/L ;PSIHP组分别为 (5 2 19 7± 5 30 2 ) ,(6 5 7± 6 4 )mg/L。两组差异有显著性 (P <0 0 1)。PSIHP组过滤后肝静脉血血药浓度峰值为 (4 0 8 7± 4 7 8)mg/L ,碳肾率过滤达到 (78 2± 7 4 ) %。结论 PSIHP是一种简单有效的肝脏隔离灌注化疗技术 ,与常规经肝动脉灌注化疗相比 ,不仅可以增加局部血药浓度 ,更可以降低外周血血药浓度 。 Objective To investigate the feasibility and the effect of percutaneous selective isolated hepatic perfusion chemotherapy(PSIHP). Methods Six pigs underwent the procedure of routine transhepatic arterial infusion(HAI) and the other 6 underwent PSIHP. 5-FU was used in our study. The plasma concentraiton of 5-FU in hepatic vein (before filtrating) and systemic vein was measured in both groups. Results The peak level of adriamycin concentration in hepatic vein (before filtrating) and systemic in HAI was ( 4?153 4±430 2) mg/L and ( 1?676 1±226 9) mg/L respectiely. In PSIHP, the peak level were( 5?219 7±530 2) mg/L and (65 7±6 4) mg/L. There were significant differences between HAI and PSIHP( P <0 01). Conclusion PSIHP is a simple and feasible method for isolated hepaitic perfusion. Compared with HAI, using the technology of PSIHP, the concentration of chemotherapeutic agents increases in regional liver and significantly decreases in systemic circulation.
出处 《广东医学》 CAS CSCD 2004年第8期881-883,共3页 Guangdong Medical Journal
基金 广东省深圳市科技局基金资助项目 (编号 :2 0 0 10 40 87)
关键词 经皮选择性肝脏隔离灌注化疗 介入放射学 血液灌流 5-FU 肝脏恶性肿瘤 Isolated liver Perfusion chemotherapy Interventional radiology
  • 相关文献

参考文献7

  • 1Creech JO, Krementz ET, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg, 1958,148(2) :616
  • 2Ku Y, Iwasaki T, Fukomoto T, et al. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg, 1998,227(2):519
  • 3Ku Y, Tominaga M, Iwasaki T, et al. Isolated hepatic perfusion chemo-therapy for unresctable malignant hepatic tumor. Int J Clin Oncol, 2002,7(1) :82
  • 4Curley SA, Byrd DR, Newman. an RA, et al. Reduction of systemic durg exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery, 1993, 114(2):579
  • 5Oldhafer KJ, Lang H, Freker M, et al. The surgical technique of isolated hyperthemic arterial liver perfusion in humans. Recent Results Caner Res,1988,147(1):42
  • 6Eggermont AMM, Van Ijken MGA, Vant Etten B, et al. Isolated hypoxic hetatic perfusion(IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology,2000,47(4) :776
  • 7Ku Y, Fukomoto T, Iwasaki T, et al. Single cather techinque of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumor. Ann J Surg, 1997,173:103

同被引文献27

  • 1邢雪,夏穗生.大鼠肝脏隔离灌注不同剂量5-氟脲嘧啶静脉血中前列环素与血栓素A_2的变化[J].中华实验外科杂志,1995,12(3):159-160. 被引量:3
  • 2叶坚,梁浩晖,何劲松,王成友,王先明,周汝明,邱水波,钱文璟.新型双球囊导管经皮选择性隔离肝脏灌注化疗的效果研究[J].岭南现代临床外科,2007,7(3):169-170. 被引量:1
  • 3Ku Y, Tominaga M, LwasakiT,et al. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors. Int J Clin Oncol,2002,7(1):82.
  • 4Creech JO, Krementz ET, Winblad JN. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg, 1958, 148:616-632.
  • 5Ku Y ,Tominaga M ,Iwasaki T, et al. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors. Int J Clin Oncol, 2002,7:82-90.
  • 6Gavriel Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Cell Biol, 1992,119:493-501.
  • 7Creech JO,Krementz ET,Winblad JN,Chemotherapy of cancer:Regional perfusion utilizing an extracorporeal circuit[J].Ann Surg,1958,148(2):616-632.
  • 8Ku Y,Tominaga M,Iwasaki T,et al.Isolated hepatic perfusion chemo-therapy for unresectable malignant hepatic tumors[J].Int J Clin Oncol,2002,7(1):82-90.
  • 9Gavriel Y,Sherman Y,Ben-Sasson SA.Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation[J].Cell Biol,1992,119(2):493-501.
  • 10Ku Y,Iwasaki T,Fukomoto T,et al.Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion[J].Ann Surg,1998,227(2):519-526.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部